Hanover wins UCB communications brief for UK

Hanover has been hired by pharmaceutical company UCB to help promote its brand in the UK.

The media agency has won a public affairs and corporate communications brief that aims to raise the profile of UCB in Britain, while also underlining the attractiveness of the UK as a favourable market for life science investment, reports PRWeek.

Andrew Harrison, Hanover's head of healthcare, will lead the six-figure, two-year account, with UCB stating that the agency's passion, enthusiasm and expertise were pivotal to its decision to award the contract.

This comes after UCB retained Fleishman-Hillard to offer global PR support for its rheumatoid arthritis treatment Cimzia last year.

Mr Harrison said: "UCB is one of the top five life science research and development investors in the UK and has a huge amount to offer patients, the NHS and this country's economic growth agenda."

Hanover was founded in 1998 and is now a 40-strong consultancy, working with FTSE 100 companies and public sector bodies, and wining strong recommendations from the majority of its clients.